Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Wearable Neuromodulation Device Market Research Report 2024

Global Wearable Neuromodulation Device Market Research Report 2024

Global Wearable Neuromodulation Device Market Research Report 2024

Industry: Medical Devices & Consumables

Published: 2024-02-07

Pages: 91 Pages

Report ld: 2463802

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

A Wearable Neuromodulation Device is a portable device used to deliver electrical or electromagnetic stimulation to specific areas of the body or brain for therapeutic purposes. It is designed to be worn on the body, typically as a headband, wristband, or patch, and delivers targeted stimulation to modulate neural activity.

The global Wearable Neuromodulation Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Wearable Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Wearable Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Wearable Neuromodulation Device include Nexalin, Cefaly, ​Theranica Bio-Electronics Ltd., Neurolief Inc., eNeura Inc., Avation Medical, NeuroMetrix, Softeq Development and Cala Health, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Wearable Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Neuromodulation Device.

Report Scope
The Wearable Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wearable Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Wearable Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global Wearable Neuromodulation Device Market Research Report 2024

  • Market Size Available for Years

  • 2024-2030

  • Global Wearable Neuromodulation Device Companies Covered

  • Nexalin

    Cefaly

    ​Theranica Bio-Electronics Ltd.

    Neurolief Inc.

    eNeura Inc.

    Avation Medical

    NeuroMetrix

    Softeq Development

    Cala Health, Inc.

    Neurotherapeutics Ltd

    BlueWind Medical

  • Global Wearable Neuromodulation Device Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Wearable Neuromodulation Device Market, Segment by Type

  • Head Mounted

    Hand-worn

    Leg-worn

    Foot-worn

  • Global Wearable Neuromodulation Device Market, Segment by Application

  • Hospital

    Clinic

    Residential

    Nursing Home

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Wearable Neuromodulation Device Market Overview
    1.1 Product Overview and Scope of Wearable Neuromodulation Device
    1.2 Wearable Neuromodulation Device Segment by Type
        1.2.1 Global Wearable Neuromodulation Device Market Value Comparison by Type (2024-2030)
        1.2.2 Head Mounted
        1.2.3 Hand-worn
        1.2.4 Leg-worn
        1.2.5 Foot-worn
    1.3 Wearable Neuromodulation Device Segment by Application
        1.3.1 Global Wearable Neuromodulation Device Market Value by Application: (2024-2030)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Residential
        1.3.5 Nursing Home
        1.3.6 Others
    1.4 Global Wearable Neuromodulation Device Market Size Estimates and Forecasts
        1.4.1 Global Wearable Neuromodulation Device Revenue 2019-2030
        1.4.2 Global Wearable Neuromodulation Device Sales 2019-2030
        1.4.3 Global Wearable Neuromodulation Device Market Average Price (2019-2030)
    1.5 Assumptions and Limitations
2 Wearable Neuromodulation Device Market Competition by Manufacturers
    2.1 Global Wearable Neuromodulation Device Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Wearable Neuromodulation Device Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Wearable Neuromodulation Device Average Price by Manufacturers (2019-2024)
    2.4 Global Wearable Neuromodulation Device Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Wearable Neuromodulation Device, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Wearable Neuromodulation Device, Product Type & Application
    2.7 Wearable Neuromodulation Device Market Competitive Situation and Trends
        2.7.1 Wearable Neuromodulation Device Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Wearable Neuromodulation Device Players Market Share by Revenue
        2.7.3 Global Wearable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Neuromodulation Device Retrospective Market Scenario by Region
    3.1 Global Wearable Neuromodulation Device Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Wearable Neuromodulation Device Global Wearable Neuromodulation Device Sales by Region: 2019-2030
        3.2.1 Global Wearable Neuromodulation Device Sales by Region: 2019-2024
        3.2.2 Global Wearable Neuromodulation Device Sales by Region: 2025-2030
    3.3 Global Wearable Neuromodulation Device Global Wearable Neuromodulation Device Revenue by Region: 2019-2030
        3.3.1 Global Wearable Neuromodulation Device Revenue by Region: 2019-2024
        3.3.2 Global Wearable Neuromodulation Device Revenue by Region: 2025-2030
    3.4 North America Wearable Neuromodulation Device Market Facts & Figures by Country
        3.4.1 North America Wearable Neuromodulation Device Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Wearable Neuromodulation Device Sales by Country (2019-2030)
        3.4.3 North America Wearable Neuromodulation Device Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Wearable Neuromodulation Device Market Facts & Figures by Country
        3.5.1 Europe Wearable Neuromodulation Device Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Wearable Neuromodulation Device Sales by Country (2019-2030)
        3.5.3 Europe Wearable Neuromodulation Device Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Wearable Neuromodulation Device Market Facts & Figures by Country
        3.6.1 Asia Pacific Wearable Neuromodulation Device Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Wearable Neuromodulation Device Sales by Country (2019-2030)
        3.6.3 Asia Pacific Wearable Neuromodulation Device Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Wearable Neuromodulation Device Market Facts & Figures by Country
        3.7.1 Latin America Wearable Neuromodulation Device Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Wearable Neuromodulation Device Sales by Country (2019-2030)
        3.7.3 Latin America Wearable Neuromodulation Device Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Wearable Neuromodulation Device Market Facts & Figures by Country
        3.8.1 Middle East and Africa Wearable Neuromodulation Device Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Wearable Neuromodulation Device Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Wearable Neuromodulation Device Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE
4 Segment by Type
    4.1 Global Wearable Neuromodulation Device Sales by Type (2019-2030)
        4.1.1 Global Wearable Neuromodulation Device Sales by Type (2019-2024)
        4.1.2 Global Wearable Neuromodulation Device Sales by Type (2025-2030)
        4.1.3 Global Wearable Neuromodulation Device Sales Market Share by Type (2019-2030)
    4.2 Global Wearable Neuromodulation Device Revenue by Type (2019-2030)
        4.2.1 Global Wearable Neuromodulation Device Revenue by Type (2019-2024)
        4.2.2 Global Wearable Neuromodulation Device Revenue by Type (2025-2030)
        4.2.3 Global Wearable Neuromodulation Device Revenue Market Share by Type (2019-2030)
    4.3 Global Wearable Neuromodulation Device Price by Type (2019-2030)
5 Segment by Application
    5.1 Global Wearable Neuromodulation Device Sales by Application (2019-2030)
        5.1.1 Global Wearable Neuromodulation Device Sales by Application (2019-2024)
        5.1.2 Global Wearable Neuromodulation Device Sales by Application (2025-2030)
        5.1.3 Global Wearable Neuromodulation Device Sales Market Share by Application (2019-2030)
    5.2 Global Wearable Neuromodulation Device Revenue by Application (2019-2030)
        5.2.1 Global Wearable Neuromodulation Device Revenue by Application (2019-2024)
        5.2.2 Global Wearable Neuromodulation Device Revenue by Application (2025-2030)
        5.2.3 Global Wearable Neuromodulation Device Revenue Market Share by Application (2019-2030)
    5.3 Global Wearable Neuromodulation Device Price by Application (2019-2030)
6 Key Companies Profiled
    6.1 Nexalin
        6.1.1 Nexalin Corporation Information
        6.1.2 Nexalin Description and Business Overview
        6.1.3 Nexalin Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Nexalin Wearable Neuromodulation Device Product Portfolio
        6.1.5 Nexalin Recent Developments/Updates
    6.2 Cefaly
        6.2.1 Cefaly Corporation Information
        6.2.2 Cefaly Description and Business Overview
        6.2.3 Cefaly Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Cefaly Wearable Neuromodulation Device Product Portfolio
        6.2.5 Cefaly Recent Developments/Updates
    6.3 ​Theranica Bio-Electronics Ltd.
        6.3.1 ​Theranica Bio-Electronics Ltd. Corporation Information
        6.3.2 ​Theranica Bio-Electronics Ltd. Description and Business Overview
        6.3.3 ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product Portfolio
        6.3.5 ​Theranica Bio-Electronics Ltd. Recent Developments/Updates
    6.4 Neurolief Inc.
        6.4.1 Neurolief Inc. Corporation Information
        6.4.2 Neurolief Inc. Description and Business Overview
        6.4.3 Neurolief Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Neurolief Inc. Wearable Neuromodulation Device Product Portfolio
        6.4.5 Neurolief Inc. Recent Developments/Updates
    6.5 eNeura Inc.
        6.5.1 eNeura Inc. Corporation Information
        6.5.2 eNeura Inc. Description and Business Overview
        6.5.3 eNeura Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 eNeura Inc. Wearable Neuromodulation Device Product Portfolio
        6.5.5 eNeura Inc. Recent Developments/Updates
    6.6 Avation Medical
        6.6.1 Avation Medical Corporation Information
        6.6.2 Avation Medical Description and Business Overview
        6.6.3 Avation Medical Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Avation Medical Wearable Neuromodulation Device Product Portfolio
        6.6.5 Avation Medical Recent Developments/Updates
    6.7 NeuroMetrix
        6.6.1 NeuroMetrix Corporation Information
        6.6.2 NeuroMetrix Description and Business Overview
        6.6.3 NeuroMetrix Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 NeuroMetrix Wearable Neuromodulation Device Product Portfolio
        6.7.5 NeuroMetrix Recent Developments/Updates
    6.8 Softeq Development
        6.8.1 Softeq Development Corporation Information
        6.8.2 Softeq Development Description and Business Overview
        6.8.3 Softeq Development Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Softeq Development Wearable Neuromodulation Device Product Portfolio
        6.8.5 Softeq Development Recent Developments/Updates
    6.9 Cala Health, Inc.
        6.9.1 Cala Health, Inc. Corporation Information
        6.9.2 Cala Health, Inc. Description and Business Overview
        6.9.3 Cala Health, Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Cala Health, Inc. Wearable Neuromodulation Device Product Portfolio
        6.9.5 Cala Health, Inc. Recent Developments/Updates
    6.10 Neurotherapeutics Ltd
        6.10.1 Neurotherapeutics Ltd Corporation Information
        6.10.2 Neurotherapeutics Ltd Description and Business Overview
        6.10.3 Neurotherapeutics Ltd Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Neurotherapeutics Ltd Wearable Neuromodulation Device Product Portfolio
        6.10.5 Neurotherapeutics Ltd Recent Developments/Updates
    6.11 BlueWind Medical
        6.11.1 BlueWind Medical Corporation Information
        6.11.2 BlueWind Medical Wearable Neuromodulation Device Description and Business Overview
        6.11.3 BlueWind Medical Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 BlueWind Medical Wearable Neuromodulation Device Product Portfolio
        6.11.5 BlueWind Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Wearable Neuromodulation Device Industry Chain Analysis
    7.2 Wearable Neuromodulation Device Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Wearable Neuromodulation Device Production Mode & Process
    7.4 Wearable Neuromodulation Device Sales and Marketing
        7.4.1 Wearable Neuromodulation Device Sales Channels
        7.4.2 Wearable Neuromodulation Device Distributors
    7.5 Wearable Neuromodulation Device Customers
8 Wearable Neuromodulation Device Market Dynamics
    8.1 Wearable Neuromodulation Device Industry Trends
    8.2 Wearable Neuromodulation Device Market Drivers
    8.3 Wearable Neuromodulation Device Market Challenges
    8.4 Wearable Neuromodulation Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Wearable Neuromodulation Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Wearable Neuromodulation Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Wearable Neuromodulation Device Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Wearable Neuromodulation Device Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Wearable Neuromodulation Device Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Wearable Neuromodulation Device Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Wearable Neuromodulation Device Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Wearable Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Wearable Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Wearable Neuromodulation Device, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Wearable Neuromodulation Device, Product Type & Application
    Table 12. Global Key Manufacturers of Wearable Neuromodulation Device, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Wearable Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Neuromodulation Device as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Wearable Neuromodulation Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Wearable Neuromodulation Device Sales by Region (2019-2024) & (K Units)
    Table 18. Global Wearable Neuromodulation Device Sales Market Share by Region (2019-2024)
    Table 19. Global Wearable Neuromodulation Device Sales by Region (2025-2030) & (K Units)
    Table 20. Global Wearable Neuromodulation Device Sales Market Share by Region (2025-2030)
    Table 21. Global Wearable Neuromodulation Device Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Wearable Neuromodulation Device Revenue Market Share by Region (2019-2024)
    Table 23. Global Wearable Neuromodulation Device Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Wearable Neuromodulation Device Revenue Market Share by Region (2025-2030)
    Table 25. North America Wearable Neuromodulation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Wearable Neuromodulation Device Sales by Country (2019-2024) & (K Units)
    Table 27. North America Wearable Neuromodulation Device Sales by Country (2025-2030) & (K Units)
    Table 28. North America Wearable Neuromodulation Device Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Wearable Neuromodulation Device Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Wearable Neuromodulation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Wearable Neuromodulation Device Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Wearable Neuromodulation Device Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Wearable Neuromodulation Device Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Wearable Neuromodulation Device Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Wearable Neuromodulation Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Wearable Neuromodulation Device Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Wearable Neuromodulation Device Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Wearable Neuromodulation Device Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Wearable Neuromodulation Device Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Wearable Neuromodulation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Wearable Neuromodulation Device Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Wearable Neuromodulation Device Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Wearable Neuromodulation Device Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Wearable Neuromodulation Device Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Wearable Neuromodulation Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Wearable Neuromodulation Device Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Wearable Neuromodulation Device Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Wearable Neuromodulation Device Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Wearable Neuromodulation Device Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Wearable Neuromodulation Device Sales (K Units) by Type (2019-2024)
    Table 51. Global Wearable Neuromodulation Device Sales (K Units) by Type (2025-2030)
    Table 52. Global Wearable Neuromodulation Device Sales Market Share by Type (2019-2024)
    Table 53. Global Wearable Neuromodulation Device Sales Market Share by Type (2025-2030)
    Table 54. Global Wearable Neuromodulation Device Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Wearable Neuromodulation Device Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Wearable Neuromodulation Device Revenue Market Share by Type (2019-2024)
    Table 57. Global Wearable Neuromodulation Device Revenue Market Share by Type (2025-2030)
    Table 58. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Wearable Neuromodulation Device Sales (K Units) by Application (2019-2024)
    Table 61. Global Wearable Neuromodulation Device Sales (K Units) by Application (2025-2030)
    Table 62. Global Wearable Neuromodulation Device Sales Market Share by Application (2019-2024)
    Table 63. Global Wearable Neuromodulation Device Sales Market Share by Application (2025-2030)
    Table 64. Global Wearable Neuromodulation Device Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Wearable Neuromodulation Device Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Wearable Neuromodulation Device Revenue Market Share by Application (2019-2024)
    Table 67. Global Wearable Neuromodulation Device Revenue Market Share by Application (2025-2030)
    Table 68. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2025-2030)
    Table 70. Nexalin Corporation Information
    Table 71. Nexalin Description and Business Overview
    Table 72. Nexalin Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Nexalin Wearable Neuromodulation Device Product
    Table 74. Nexalin Recent Developments/Updates
    Table 75. Cefaly Corporation Information
    Table 76. Cefaly Description and Business Overview
    Table 77. Cefaly Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Cefaly Wearable Neuromodulation Device Product
    Table 79. Cefaly Recent Developments/Updates
    Table 80. ​Theranica Bio-Electronics Ltd. Corporation Information
    Table 81. ​Theranica Bio-Electronics Ltd. Description and Business Overview
    Table 82. ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product
    Table 84. ​Theranica Bio-Electronics Ltd. Recent Developments/Updates
    Table 85. Neurolief Inc. Corporation Information
    Table 86. Neurolief Inc. Description and Business Overview
    Table 87. Neurolief Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Neurolief Inc. Wearable Neuromodulation Device Product
    Table 89. Neurolief Inc. Recent Developments/Updates
    Table 90. eNeura Inc. Corporation Information
    Table 91. eNeura Inc. Description and Business Overview
    Table 92. eNeura Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. eNeura Inc. Wearable Neuromodulation Device Product
    Table 94. eNeura Inc. Recent Developments/Updates
    Table 95. Avation Medical Corporation Information
    Table 96. Avation Medical Description and Business Overview
    Table 97. Avation Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Avation Medical Wearable Neuromodulation Device Product
    Table 99. Avation Medical Recent Developments/Updates
    Table 100. NeuroMetrix Corporation Information
    Table 101. NeuroMetrix Description and Business Overview
    Table 102. NeuroMetrix Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. NeuroMetrix Wearable Neuromodulation Device Product
    Table 104. NeuroMetrix Recent Developments/Updates
    Table 105. Softeq Development Corporation Information
    Table 106. Softeq Development Description and Business Overview
    Table 107. Softeq Development Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Softeq Development Wearable Neuromodulation Device Product
    Table 109. Softeq Development Recent Developments/Updates
    Table 110. Cala Health, Inc. Corporation Information
    Table 111. Cala Health, Inc. Description and Business Overview
    Table 112. Cala Health, Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Cala Health, Inc. Wearable Neuromodulation Device Product
    Table 114. Cala Health, Inc. Recent Developments/Updates
    Table 115. Neurotherapeutics Ltd Corporation Information
    Table 116. Neurotherapeutics Ltd Description and Business Overview
    Table 117. Neurotherapeutics Ltd Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Neurotherapeutics Ltd Wearable Neuromodulation Device Product
    Table 119. Neurotherapeutics Ltd Recent Developments/Updates
    Table 120. BlueWind Medical Corporation Information
    Table 121. BlueWind Medical Description and Business Overview
    Table 122. BlueWind Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. BlueWind Medical Wearable Neuromodulation Device Product
    Table 124. BlueWind Medical Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Wearable Neuromodulation Device Distributors List
    Table 128. Wearable Neuromodulation Device Customers List
    Table 129. Wearable Neuromodulation Device Market Trends
    Table 130. Wearable Neuromodulation Device Market Drivers
    Table 131. Wearable Neuromodulation Device Market Challenges
    Table 132. Wearable Neuromodulation Device Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Wearable Neuromodulation Device
    Figure 2. Global Wearable Neuromodulation Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Wearable Neuromodulation Device Market Share by Type in 2023 & 2030
    Figure 4. Head Mounted Product Picture
    Figure 5. Hand-worn Product Picture
    Figure 6. Leg-worn Product Picture
    Figure 7. Foot-worn Product Picture
    Figure 8. Global Wearable Neuromodulation Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Wearable Neuromodulation Device Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Residential
    Figure 13. Nursing Home
    Figure 14. Others
    Figure 15. Global Wearable Neuromodulation Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Wearable Neuromodulation Device Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Wearable Neuromodulation Device Sales (2019-2030) & (K Units)
    Figure 18. Global Wearable Neuromodulation Device Average Price (US$/Unit) & (2019-2030)
    Figure 19. Wearable Neuromodulation Device Report Years Considered
    Figure 20. Wearable Neuromodulation Device Sales Share by Manufacturers in 2023
    Figure 21. Global Wearable Neuromodulation Device Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Wearable Neuromodulation Device Players: Market Share by Revenue in 2023
    Figure 23. Wearable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Wearable Neuromodulation Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Wearable Neuromodulation Device Sales Market Share by Country (2019-2030)
    Figure 26. North America Wearable Neuromodulation Device Revenue Market Share by Country (2019-2030)
    Figure 27. United States Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Wearable Neuromodulation Device Sales Market Share by Country (2019-2030)
    Figure 30. Europe Wearable Neuromodulation Device Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Wearable Neuromodulation Device Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Wearable Neuromodulation Device Revenue Market Share by Region (2019-2030)
    Figure 38. China Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Wearable Neuromodulation Device Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Wearable Neuromodulation Device Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Wearable Neuromodulation Device Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Wearable Neuromodulation Device Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Wearable Neuromodulation Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Wearable Neuromodulation Device by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Wearable Neuromodulation Device by Type (2019-2030)
    Figure 57. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Wearable Neuromodulation Device by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Wearable Neuromodulation Device by Application (2019-2030)
    Figure 60. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2019-2030)
    Figure 61. Wearable Neuromodulation Device Value Chain
    Figure 62. Wearable Neuromodulation Device Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description 

A Wearable Neuromodulation Device is a portable device used to deliver electrical or electromagnetic stimulation to specific areas of the body or brain for therapeutic purposes. It is designed to be worn on the body, typically as a headband, wristband, or patch, and delivers targeted stimulation to modulate neural activity.

The global Wearable Neuromodulation Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Wearable Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Wearable Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Wearable Neuromodulation Device include Nexalin, Cefaly, ​Theranica Bio-Electronics Ltd., Neurolief Inc., eNeura Inc., Avation Medical, NeuroMetrix, Softeq Development and Cala Health, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Wearable Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Neuromodulation Device.

Report Scope
The Wearable Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wearable Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Wearable Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
den_biaoTiZhungShi

Related Reports

Global Wearable Neuromodulation Device Market Research Report 2024

Industry: Medical Devices & Consumables

Published: 2024-02-07

Pages: 91 Pages

Report ld: 2463802

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now